{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:24:37Z","timestamp":1787023477529,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"DOI":"10.1007\/s11934-026-01350-3","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:45Z","timestamp":1787020305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Role of Hyperbaric Oxygen Therapy in Radiation Cystitis"],"prefix":"10.1007","volume":"27","author":[{"given":"Stephen A.","family":"Harrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"1350_CR1","doi-asserted-by":"publisher","unstructured":"GBD 2023 Cancer Collaborators. The global, regional, and national burden of cancer, 1990\u20132023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025;406(10512):1565\u201386. https:\/\/doi.org\/10.1016\/S0140-6736(25)01635-6.","DOI":"10.1016\/S0140-6736(25)01635-6."},{"key":"1350_CR2","volume-title":"Cancer Treatment & Survivorship Facts & Figs.\u00a02019\u20132021","author":"American Cancer Society","year":"2019","unstructured":"American Cancer Society. Cancer Treatment & Survivorship Facts & Figs.\u00a02019\u20132021. Atlanta: American Cancer Society; 2019."},{"key":"1350_CR3","doi-asserted-by":"publisher","unstructured":"Prise KM, O\u2019Sullivan JM. Radiation-induced bystander signalling in cancer therapy. Nat Rev Cancer. 2009;9(5):351\u201360. https:\/\/doi.org\/10.1038\/nrc2603.","DOI":"10.1038\/nrc2603."},{"key":"1350_CR4","doi-asserted-by":"publisher","unstructured":"Kim JH, Brown SL, Gordon MN. Radiation-induced senescence: therapeutic opportunities. Radiat Oncol. 2023;18(1):10. https:\/\/doi.org\/10.1186\/s13014-022-02184-2.","DOI":"10.1186\/s13014-022-02184-2."},{"key":"1350_CR5","doi-asserted-by":"publisher","unstructured":"Di Maggio FM, Minafra L, Forte GI, Cammarata FP, Lio D, Messa C, et al. Portrait of inflammatory response to ionizing radiation treatment. J Inflamm (Lond). 2015;12:14. https:\/\/doi.org\/10.1186\/s12950-015-0058-3.","DOI":"10.1186\/s12950-015-0058-3."},{"key":"1350_CR6","doi-asserted-by":"publisher","unstructured":"Mota S, Goodyke A, Ward EP, Mahyoob R, Lee YC, Bartolone SN, et al. Senescence-driven inflammation and immune dynamics in the progression of radiation cystitis. Cells. 2026;15(4). https:\/\/doi.org\/10.3390\/cells15040337.","DOI":"10.3390\/cells15040337."},{"key":"1350_CR7","unstructured":"Group RTO. RTOG\/EORTC Late Radiation Morbidity Scoring Schema. https:\/\/www.rtog.org\/ResearchAssociates\/AdverseEventReporting\/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx."},{"key":"1350_CR8","doi-asserted-by":"crossref","unstructured":"Nout RA, Creutzberg CL. Point: Vaginal brachytherapy should be a standard adjuvant treatment for intermediate-risk endometrial cancer. Brachytherapy. 2011;10(1):1\u20133.","DOI":"10.1016\/j.brachy.2010.11.002"},{"key":"1350_CR9","doi-asserted-by":"publisher","unstructured":"Erekson EA, Sung VW, DiSilvestro PA, Myers DL. Urinary symptoms and impact on quality of life in women after treatment for endometrial cancer. Int Urogynecol J Pelvic Floor Dysfunct. 2009;20(2):159\u201363. https:\/\/doi.org\/10.1007\/s00192-008-0755-z.","DOI":"10.1007\/s00192-008-0755-z."},{"key":"1350_CR10","doi-asserted-by":"publisher","unstructured":"Moses RA, Hunter AE, Brandes ER, Zhang Z, Rees JR, Peacock JL, et al. Patient-reported outcome measures following hyperbaric oxygen therapy for radiation cystitis: early results from the multicenter registry for hyperbaric oxygen therapy. J Urol. 2024;211(6):765\u201372. https:\/\/doi.org\/10.1097\/JU.0000000000003929.","DOI":"10.1097\/JU.0000000000003929."},{"key":"1350_CR11","doi-asserted-by":"crossref","unstructured":"Oscarsson N, M\u00fcller B, Ros\u00e9n A, Lodding P, M\u00f6lne J, Giglio D, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): a randomised, controlled, phase 2\u20133 trial. Lancet Oncol. 2019;20(11):1602\u201314. 2045(19)30494-2","DOI":"10.1016\/S1470-2045(19)30494-2"},{"key":"1350_CR12","doi-asserted-by":"publisher","unstructured":"Zwaans BMM, Lamb LE, Bartolone S, Nicolai HE, Chancellor MB, Klaudia SW. Cancer survivorship issues with radiation and hemorrhagic cystitis in gynecological malignancies. International Urology and Nephrology. Springer Netherlands; 2018. pp. 1745\u201351. https:\/\/doi.org\/10.1007\/s11255-018-1970-2.","DOI":"10.1007\/s11255-018-1970-2."},{"key":"1350_CR13","unstructured":"Bellemare R, Brown LK, Bihrle W, Myers JB, Buckey JC, Buckley JC, Moses RA. Exploring radiation cystitis diagnosis and management including hyperbaric oxygen therapy: a survey of reconstructive urologists practice patterns. Paper presented at: American Urological Association 09\/05\/2024, 2025; Las Vegas, NV."},{"key":"1350_CR14","doi-asserted-by":"publisher","unstructured":"Zwaans BMM, Nicolai HG, Chancellor MB, Lamb LE. Challenges and opportunities in radiation-induced hemorrhagic cystitis. Rev Urol. 2016;18(2):57\u201365. https:\/\/doi.org\/10.3909\/riu0700.","DOI":"10.3909\/riu0700."},{"key":"1350_CR15","doi-asserted-by":"publisher","unstructured":"Osterberg EC, Vanni AJ, Gaither TW, Awad MA, Broghammer JA, Pate SC, et al. Radiation-induced complex anterior urinary fistulation for prostate cancer: a retrospective multicenter study from the Trauma and Urologic Reconstruction Network of Surgeons (TURNS). World J Urol. 2017;35(7):1037\u201343. https:\/\/doi.org\/10.1007\/s00345-016-1983-3.","DOI":"10.1007\/s00345-016-1983-3."},{"key":"1350_CR16","doi-asserted-by":"publisher","unstructured":"Bassett MR, Santiago-Lastra Y, Stoffel JT, Goldfarb R, Elliott SP, Pate SC, et al. Urinary diversion for severe urinary adverse events of prostate radiation: results from a multi-institutional study. J Urol. 2017;197(3 Pt 1):744\u201350. https:\/\/doi.org\/10.1016\/j.juro.2016.10.091.","DOI":"10.1016\/j.juro.2016.10.091."},{"key":"1350_CR17","doi-asserted-by":"publisher","unstructured":"Mayer EN, Tward JD, Bassett M, Lenherr SM, Hotaling JM, Brant WO, et al. Management of radiation therapy oncology group grade 4 urinary adverse events after radiotherapy for prostate cancer. BJU Int. 2017;119(5):700\u20138. https:\/\/doi.org\/10.1111\/bju.13607.","DOI":"10.1111\/bju.13607."},{"key":"1350_CR18","unstructured":"Di Franco R, Borzillo V, Ravo V, Ametrano G, Cammarota F, Rossetti S, et al. Rectal\/urinary toxicity after hypofractionated vs. conventional radiotherapy in high risk prostate cancer: systematic review and meta analysis. Eur Rev Med Pharmacol Sci. 2017;21(16):3563\u201375."},{"key":"1350_CR19","doi-asserted-by":"publisher","unstructured":"Fu Q, Duan R, Sun Y, Li Q. Hyperbaric oxygen therapy for healthy aging: From mechanisms to therapeutics. Redox Biol. 2022;53:102352. https:\/\/doi.org\/10.1016\/j.redox.2022.102352.","DOI":"10.1016\/j.redox.2022.102352."},{"key":"1350_CR20","doi-asserted-by":"publisher","unstructured":"Oscarsson N, Ny L, M\u00f6lne J, Lind F, Ricksten SE, Seeman-Lodding H, et al. Hyperbaric oxygen treatment reverses radiation induced pro-fibrotic and oxidative stress responses in a rat model. Free Radic Biol Med. 2017;103:248\u201355. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.12.036.","DOI":"10.1016\/j.freeradbiomed.2016.12.036."},{"key":"1350_CR21","doi-asserted-by":"publisher","unstructured":"Cardinal J, Slade A, McFarland M, Keihani S, Hotaling JN, Myers JB. Scoping review and meta-analysis of hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. current urology reports. current medicine group LLC 1; 2018. https:\/\/doi.org\/10.1007\/s11934-018-0790-3.","DOI":"10.1007\/s11934-018-0790-3."},{"key":"1350_CR22","doi-asserted-by":"publisher","unstructured":"Hamdy FC, Donovan JL. Fifteen-year outcomes of the protect trial for localized prostate cancer. Reply. N Engl J Med. 2023;389(1):92. https:\/\/doi.org\/10.1056\/NEJMc2306135.","DOI":"10.1056\/NEJMc2306135."},{"key":"1350_CR23","doi-asserted-by":"crossref","unstructured":"Lim RS, Loehrer E, Dagrosa A, Buckey L, Moses JC. RA patient demographic factors associated with radiation cystitis development following radiation for prostate cancer. Am Urol Association 04\/2025, 2024; Las Vegas, NV.","DOI":"10.1097\/01.JU.0001110184.48142.9e.07"},{"key":"1350_CR24","doi-asserted-by":"publisher","unstructured":"Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys. 2008;70(4):1124\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.11.044.","DOI":"10.1016\/j.ijrobp.2007.11.044."},{"key":"1350_CR25","doi-asserted-by":"publisher","unstructured":"Martin SE, Begun EM, Samir E, Azaiza MT, Allegro S, Abdelhady M. incidence and morbidity of radiation-induced hemorrhagic cystitis in prostate cancer. Urology. 2019;131:190\u20135. https:\/\/doi.org\/10.1016\/j.urology.2019.05.034.","DOI":"10.1016\/j.urology.2019.05.034."},{"key":"1350_CR26","doi-asserted-by":"crossref","unstructured":"Afonso-Jo\u00e3o D, Pacheco-Figueiredo L, Antunes-Lopes T, Morgado LA, Azevedo V, Vendeira L et al. Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer. Actas Urol Esp [Internet]. 2018. Report. Available from: www.elsevier.es\/actasuro.","DOI":"10.1016\/j.acuroe.2018.03.006"},{"key":"1350_CR27","doi-asserted-by":"publisher","unstructured":"Makino K, Sato Y, Takenaka R, Yamashita H, Akiyama Y, Yamada Y, et al. Cumulative incidence and clinical risk factors of radiation cystitis after radiotherapy for prostate cancer. Urol Int. 2023;107(5):440\u20136. doi:https:\/\/doi.org\/10.1159\/000521723.","DOI":"10.1159\/000521723."},{"key":"1350_CR28","doi-asserted-by":"publisher","unstructured":"Liem X, Saad F, Delouya G. A practical approach to the management of radiation-induced hemorrhagic cystitis. drugs. Springer International Publishing; 2015. pp. 1471\u201382. https:\/\/doi.org\/10.1007\/s40265-015-0443-5.","DOI":"10.1007\/s40265-015-0443-5."},{"key":"1350_CR29","doi-asserted-by":"publisher","unstructured":"Lee V, An Y, Park HS, Yu JB, Kim SP, Jairam V. Emergency department visits for radiation cystitis among patients with a prostate cancer history. BJU Int. 2022;130(2):208\u201316. https:\/\/doi.org\/10.1111\/bju.15650..","DOI":"10.1111\/bju.15650."},{"key":"1350_CR30","doi-asserted-by":"publisher","unstructured":"Arora S, Chen I, Bronkema C, Chiarelli G, Finati M, Cirulli GO, et al. Admission rates, healthcare utilization, and inpatient cost of radiation cystitis in the United States. Urology. 2024;184:94\u2013100. https:\/\/doi.org\/10.1016\/j.urology.2023.12.008.","DOI":"10.1016\/j.urology.2023.12.008."},{"key":"1350_CR31","doi-asserted-by":"publisher","unstructured":"Kaplan JR, Wolf JS. Efficacy and survival associated with cystoscopy and clot evacuation for radiation or cyclophosphamide induced hemorrhagic cystitis. J Urol. 2009;181(2):641\u20136. https:\/\/doi.org\/10.1016\/j.juro.2008.10.037.","DOI":"10.1016\/j.juro.2008.10.037."},{"key":"1350_CR32","doi-asserted-by":"publisher","unstructured":"Zwaans BMM, Chancellor MB, Lamb LE. Modeling and treatment of radiation cystitis. Urology. Elsevier Inc.; 2016. pp. 14\u201321. https:\/\/doi.org\/10.1016\/j.urology.2015.11.001.","DOI":"10.1016\/j.urology.2015.11.001."},{"key":"1350_CR33","doi-asserted-by":"publisher","unstructured":"Yoshida T, Kawashima A, Ujike T, Uemura M, Nishimura K, Miyoshi S. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. Int J Urol. 2008;15(7):639\u201341. https:\/\/doi.org\/10.1111\/j.1442-2042.2008.02053.x.","DOI":"10.1111\/j.1442-2042.2008.02053.x."},{"key":"1350_CR34","doi-asserted-by":"publisher","unstructured":"Morris K, Al, Haboubi NY. Pelvic radiation therapy: Between delight and disaster. World J Gastrointest Surg. 2015;7(11):279\u201388. https:\/\/doi.org\/10.4240\/wjgs.v7.i11.279.","DOI":"10.4240\/wjgs.v7.i11.279."},{"key":"1350_CR35","doi-asserted-by":"publisher","unstructured":"Zwaans BMM, Krueger S, Bartolone SN, Chancellor MB, Marples B, Lamb LE. Modeling of chronic radiation-induced cystitis in mice. Adv Radiat Oncol. 2016;1(4):333\u201343. https:\/\/doi.org\/10.1016\/j.adro.2016.07.004.","DOI":"10.1016\/j.adro.2016.07.004."},{"key":"1350_CR36","doi-asserted-by":"publisher","unstructured":"Brossard C, Lefranc AC, Simon JM, Benderitter M, Milliat F, Chapel A. Understanding molecular mechanisms and identifying key processes in chronic radiation cystitis. Int J Mol Sci MDPI. 2022. https:\/\/doi.org\/10.3390\/ijms23031836.","DOI":"10.3390\/ijms23031836."},{"key":"1350_CR37","doi-asserted-by":"publisher","unstructured":"Helissey C, Cavallero S, Brossard C, Dusaud M, Chargari C, Fran\u00e7ois S. Chronic inflammation and radiation-induced cystitis: Molecular background and therapeutic perspectives. Cells MDPI. 2021;1\u201320. https:\/\/doi.org\/10.3390\/cells10010021.","DOI":"10.3390\/cells10010021."},{"key":"1350_CR38","doi-asserted-by":"publisher","unstructured":"Zwaans BMM, Wegner KA, Bartolone SN, Vezina CM, Chancellor MB, Lamb LE. Radiation cystitis modeling: A comparative study of bladder fibrosis radio-sensitivity in C57BL\/6, C3H, and BALB\/c mice. Physiol Rep. 2020;8(4). https:\/\/doi.org\/10.14814\/phy2.14377.","DOI":"10.14814\/phy2.14377."},{"key":"1350_CR39","doi-asserted-by":"publisher","unstructured":"Manea E, Escande A, Bockel S, Khettab M, Dumas I, Lazarescu I, et al. Risk of late urinary complications following image guided adaptive brachytherapy for locally advanced cervical cancer: refining bladder dose-volume parameters. Int J Radiat Oncol Biol Phys. 2018;101(2):411\u201320. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.02.004.","DOI":"10.1016\/j.ijrobp.2018.02.004."},{"key":"1350_CR40","doi-asserted-by":"crossref","unstructured":"Capelli-Schellpfeffer M, Gerber GS. The use of hyperbaric oxygen in urology. Report; 1999.","DOI":"10.1097\/00005392-199909010-00002"},{"key":"1350_CR41","doi-asserted-by":"publisher","unstructured":"Lindenmann J, Kamolz L, Graier W, Smolle J, Smolle-Juettner FM. Hyperbaric oxygen therapy and tissue regeneration: a literature survey. Biomedicines. 2022;10(12). https:\/\/doi.org\/10.3390\/biomedicines10123145.","DOI":"10.3390\/biomedicines10123145."},{"key":"1350_CR42","doi-asserted-by":"publisher","unstructured":"Verma R, Chopra A, Giardina C, Sabbisetti V, Smyth JA, Hightower LE, et al. Hyperbaric oxygen therapy (HBOT) suppresses biomarkers of cell stress and kidney injury in diabetic mice. Cell Stress Chaperones. 2015;20(3):495\u2013505. https:\/\/doi.org\/10.1007\/s12192-015-0574-3.","DOI":"10.1007\/s12192-015-0574-3."},{"key":"1350_CR43","doi-asserted-by":"publisher","unstructured":"Sarri\u00f3-Sanz P, Sanchez-Caballero L, Martinez-Cayuelas L, Gori CF, Pacheco-Bru JJ, Nakdali-Kassab B, et al. Efficacy, tolerance and predictors of response to the treatment with hyperbaric oxygen therapy for patients with hemorrhagic radiation cystitis. Arch Esp Urol. 2022;75(4):354\u201360. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20227504.50.","DOI":"10.56434\/j.arch.esp.urol.20227504.50."},{"key":"1350_CR44","doi-asserted-by":"publisher","unstructured":"Weiss JP, Boland FP, Mori H, Gallagher M, Brereton H, Preate DL, et al. Treatment of radiation-induced cystitis with hyperbaric oxygen. J Urol. 1985;134(2):352\u20134. https:\/\/doi.org\/10.1016\/s0022-5347(17)47166-7.","DOI":"10.1016\/s0022-5347(17)47166-7."},{"key":"1350_CR45","unstructured":"Hyperbaric oxygen therapy indications. Richard E. Moon, MD, chair and editor. Undersea and Hyperbaric Medical Society. Hyperbaric Oxygen Committee, author. In: Moon RE, editor. North Palm Beach. FL, USA: Best Publishing Company; 2019. Library Catalog ; MMS ID 9917554153406676; ISBN 9781947239166; NLM Unique ID 101755415."},{"key":"1350_CR46","doi-asserted-by":"publisher","unstructured":"Chong KT, Hampson NB, Corman JM. Early hyperbaric oxygen therapy improves outcome for radiation-induced hemorrhagic cystitis. Urology. 2005;65(4):649\u201353. https:\/\/doi.org\/10.1016\/j.urology.2004.10.050.","DOI":"10.1016\/j.urology.2004.10.050."},{"key":"1350_CR47","doi-asserted-by":"publisher","unstructured":"Soriano VH, Laspro M, Lee WY, Parker S, Taneja SS, Brucker B, et al. Outcomes of hyperbaric oxygen therapy at 2.0 Versus 2.5 ATA for Hemorrhagic radiation cystitis. neurourol urodyn. 2026. https:\/\/doi.org\/10.1002\/nau.70221.","DOI":"10.1002\/nau.70221."},{"key":"1350_CR48","doi-asserted-by":"publisher","unstructured":"Ajayi OD, Gaskill Z, Kelly M, Logue CJ, Hendricksen SM. A comparison of two hyperbaric oxygen regimens: 2.0 ATA for 120 minutes to 2.4 ATA for 90 minutes in treating radiation-induced cystitis Are these regimens equivalent? Undersea Hyperb Med. 2020;47(4):581\u20139. https:\/\/doi.org\/10.22462\/10.12.2020.7.","DOI":"10.22462\/10.12.2020.7."},{"key":"1350_CR49","doi-asserted-by":"publisher","unstructured":"Norkool DM, Hampson NB, Gibbons RP, Weissman RM. Hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis. J Urol. 1993;150(2 Pt 1):332\u20134. https:\/\/doi.org\/10.1016\/s0022-5347(17)35476-9.","DOI":"10.1016\/s0022-5347(17)35476-9."},{"key":"1350_CR50","doi-asserted-by":"publisher","unstructured":"Weiss JP, Mattei DM, Neville EC, Hanno PM. Primary treatment of radiation-induced hemorrhagic cystitis with hyperbaric oxygen: 10-year experience. J Urol. 1994;151(6):1514\u20137. https:\/\/doi.org\/10.1016\/s0022-5347(17)35289-8.","DOI":"10.1016\/s0022-5347(17)35289-8."},{"key":"1350_CR51","unstructured":"Lee HC, Liu CS, Chiao C, Lin SN. Hyperbaric oxygen therapy in hemorrhagic radiation cystitis: a report of 20 cases. Undersea Hyperb Med. 1994;21(3):321\u20137."},{"key":"1350_CR52","doi-asserted-by":"crossref","unstructured":"Bevers R, Bakker D, Kurth K. Hyperbaric oxygen treatment for haemorrhagic radiation cystitis. Report; 1995.","DOI":"10.1016\/S0140-6736(95)91620-2"},{"key":"1350_CR53","doi-asserted-by":"crossref","unstructured":"Mathews R, Rajan N, Josefson L, Camporesi E, Makhuli Z. Hyperbaric oxygen therapy for radiation induced hemorrhagic cystitis. J Urol. 1999;161(2):435\u20137.","DOI":"10.1016\/S0022-5347(01)61914-1"},{"key":"1350_CR54","doi-asserted-by":"publisher","unstructured":"Corman JM, McClure D, Pritchett R, Kozlowski P, Hampson NB. Treatment of radiation induced hemorrhagic cystitis with hyperbaric oxygen. J Urol. 2003;169(6):2200\u20132. https:\/\/doi.org\/10.1097\/01.ju.0000063640.41307.c9.","DOI":"10.1097\/01.ju.0000063640.41307.c9."},{"key":"1350_CR55","doi-asserted-by":"publisher","unstructured":"Neheman A, Nativ O, Moskovitz B, Melamed Y, Stein A. Hyperbaric oxygen therapy for radiation-induced haemorrhagic cystitis. BJU Int. 2005;96(1):107\u20139. https:\/\/doi.org\/10.1111\/j.1464-410X.2005.05577.x.","DOI":"10.1111\/j.1464-410X.2005.05577.x."},{"key":"1350_CR56","doi-asserted-by":"publisher","unstructured":"Mohamad Al-Ali B, Trummer H, Shamloul R, Zigeuner R, Pummer K. Is treatment of hemorrhagic radiation cystitis with hyperbaric oxygen effective? Urol Int. 2010;84(4):467\u201370. https:\/\/doi.org\/10.1159\/000296289.","DOI":"10.1159\/000296289."},{"key":"1350_CR57","doi-asserted-by":"publisher","unstructured":"Shao Y, Lu GL, Shen ZJ. Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int. 2012;109(5):691\u20134. https:\/\/doi.org\/10.1111\/j.1464-410X2011.10550.x.","DOI":"10.1111\/j.1464-410X2011.10550.x."},{"key":"1350_CR58","doi-asserted-by":"publisher","unstructured":"Oliai C, Fisher B, Jani A, Wong M, Poli J, Brady LW, et al. Hyperbaric oxygen therapy for radiation-induced cystitis and proctitis. Int J Radiat Oncol Biol Phys. 2012;84(3):733\u201340. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.12.056.","DOI":"10.1016\/j.ijrobp.2011.12.056."},{"key":"1350_CR59","doi-asserted-by":"publisher","unstructured":"Polom W, Klejnotowska A, Matuszewski M, Sicko Z, Markuszewski M, Krajka K. Hyperbaric oxygen therapy (HBOT) in case of hemorrhagic cystitis after radiotherapy. Cent Eur J Urol. 2012;65(4):200\u20133. https:\/\/doi.org\/10.5173\/ceju.2012.04.art4.","DOI":"10.5173\/ceju.2012.04.art4."},{"key":"1350_CR60","doi-asserted-by":"publisher","unstructured":"Nakada T, Nakada H, Yoshida Y, Nakashima Y, Banya Y, Fujihira T, et al. Hyperbaric oxygen therapy for radiation cystitis in patients with prostate cancer: a long-term follow-up study. Urol Int. 2012;89(2):208\u201314. doi:https:\/\/doi.org\/10.1159\/000338910.","DOI":"10.1159\/000338910."},{"key":"1350_CR61","unstructured":"Shilo Y, Efrati S, Simon Z, Sella A, Gez E, Fenig E, et al. Hyperbaric oxygen therapy for hemorrhagic radiation cystitis. Isr Med Assoc J. 2013;15(2):75\u20138."},{"key":"1350_CR62","doi-asserted-by":"publisher","unstructured":"Liss MA, Osann K, Cho J, Chua WC, Dash A. Severity of hematuria effects resolution in patients treated with hyperbaric oxygen therapy for radiation-induced hematuria. Urol Int. 2013;91(4):451\u20135. doi:https:\/\/doi.org\/10.1159\/000351331.","DOI":"10.1159\/000351331."},{"key":"1350_CR63","doi-asserted-by":"publisher","unstructured":"Dellis A, Deliveliotis C, Kalentzos V, Vavasis P, Skolarikos A. Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? A prospective pilot-feasibility study and review of literature. Int Braz J Urol. 2014;40(3):296\u2013305. doi:https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2014.03.02.","DOI":"10.1590\/S1677-5538.IBJU.2014.03.02."},{"key":"1350_CR64","doi-asserted-by":"publisher","unstructured":"Tahir ARM, Westhuyzen J, Dass J, Collins MK, Webb R, Hewitt S, et al. Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia\u2019s largest study. Asia Pac J Clin Oncol. 2015;11(1):68\u201377. https:\/\/doi.org\/10.1111\/ajco.12289.","DOI":"10.1111\/ajco.12289."},{"key":"1350_CR65","doi-asserted-by":"publisher","unstructured":"Ribeiro de Oliveira TM, Carmelo Rom\u00e3o AJ, Gamito Guerreiro FM, Matos Lopes TM. Hyperbaric oxygen therapy for refractory radiation-induced hemorrhagic cystitis. Int J Urol. 2015;22(10):962\u20136. https:\/\/doi.org\/10.1111\/iju.12857.","DOI":"10.1111\/iju.12857."},{"key":"1350_CR66","doi-asserted-by":"publisher","unstructured":"Degener S, Pohle A, Strelow H, Mathers MJ, Zumb\u00e9 J, Roth S, et al. Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis. BMC Urol. 2015;15:38. https:\/\/doi.org\/10.1186\/s12894-015-0035-4.","DOI":"10.1186\/s12894-015-0035-4."},{"key":"1350_CR67","doi-asserted-by":"publisher","unstructured":"Mougin J, Souday V, Martin F, Azzouzi AR, Bigot P. Evaluation of hyperbaric oxygen therapy in the treatment of radiation-induced hemorrhagic cystitis. Urology. 2016;94:42\u20136. https:\/\/doi.org\/10.1016\/j.urology.201604.015.","DOI":"10.1016\/j.urology.201604.015."},{"key":"1350_CR68","unstructured":"Chong V, Rice M. The effectiveness of hyperbaric oxygen therapy (HBOT) in radiation-induced haemorrhagic cystitis. N Z Med J. 2016;129(1446):79\u201383."},{"key":"1350_CR69","doi-asserted-by":"publisher","unstructured":"Dellis A, Papatsoris A, Kalentzos V, Deliveliotis C, Skolarikos A. Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis. Int Braz J Urol. 2017;43(3):489\u201395. doi:https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0451.","DOI":"10.1590\/S1677-5538.IBJU.2016.0451."},{"key":"1350_CR70","doi-asserted-by":"publisher","unstructured":"Pereira D, Ferreira C, Catarino R, Correia T, Cardoso A, Reis F, et al. Hyperbaric oxygen for radiation-induced cystitis: A long-term follow-up. Actas Urol Esp. 2020;44(8):561\u20137. https:\/\/doi.org\/10.1016\/j.acuro.2020.03.010.","DOI":"10.1016\/j.acuro.2020.03.010."},{"key":"1350_CR71","unstructured":"Ponce Blasco P, S\u00e1nchez Llopis A, Barrios Arnau L, Salvador Mar\u00edn M, Di Capua Sacoto C, Rodrigo Aliaga M. [Hyperbaric oxygen therapy efficacy in the treatment of hematuria due to radiation cystitis. Experience in a reference center]. Arch Esp Urol. 2021;74(2):215\u201323."},{"key":"1350_CR72","doi-asserted-by":"publisher","unstructured":"Villeirs L, Tailly T, Ost P, Waterloos M, Decaestecker K, Fonteyne V, et al. Hyperbaric oxygen therapy for radiation cystitis after pelvic radiotherapy: Systematic review of the recent literature. Int J Urol. 2020;27(2):98\u2013107. https:\/\/doi.org\/10.1111\/iju.14130.","DOI":"10.1111\/iju.14130."},{"key":"1350_CR73","doi-asserted-by":"publisher","unstructured":"Yang TK, Wang YJ, Li HJ, Yu YF, Huang KW, Cheng JCH. Efficacy and safety of hyperbaric oxygen therapy for radiation-induced hemorrhagic cystitis: a systematic review and meta-analysis. J Clin Med. 2024;13(16). https:\/\/doi.org\/10.3390\/jcm13164724.","DOI":"10.3390\/jcm13164724."},{"key":"1350_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103214","author":"N Oscarsson","year":"2025","unstructured":"Oscarsson N, Ros\u00e9n A, M\u00fcller B, Koskela LR, Giglio D, Kjellberg A, et al. Radiation-induced cystitis treated with hyperbaric oxygen therapy (RICH-ART): long-term follow-up of a randomised controlled, phase 2\u20133 trial. EClinicalMedicine. 2025. https:\/\/doi.org\/10.1016\/j.eclinm.2025.103214.","journal-title":"EClinicalMedicine"},{"key":"1350_CR75","doi-asserted-by":"publisher","unstructured":"Oscarsson N, Arnell P, Lodding P, Ricksten SE, Seeman-Lodding H. Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery. Int J Radiat Oncol Biol Phys. 2013;87(4):670\u20135. doi:https:\/\/doi.org\/10.1016\/j.ijrobp.2013.07.039.","DOI":"10.1016\/j.ijrobp.2013.07.039."},{"key":"1350_CR76","doi-asserted-by":"publisher","unstructured":"Goucher G, Saad F, Lukka H, Kapoor A. Canadian urological association best practice report: diagnosis and management of radiation-induced hemorrhagic cystitis. Can Urol Assoc J. 2019;13(2):15\u201323. https:\/\/doi.org\/10.5489\/cuaj.5788.","DOI":"10.5489\/cuaj.5788."},{"key":"1350_CR77","doi-asserted-by":"crossref","unstructured":"Laspro M, Wei LW, Brydges HT, Gorenstein SA, Huang ET, Chiu ES. Hyperbaric oxygen therapy regimens, treated conditions, and adverse effect profile: an undersea and hyperbaric medical society survey study. Undersea Hyperb Med. 2024;51(4):369\u201376.","DOI":"10.22462\/680"},{"key":"1350_CR78","doi-asserted-by":"crossref","unstructured":"Harlan NP, Ptak JA, Rees JR, Cowan DR, Fellows AM, Moses RA, et al. International Multicenter Registry for Hyperbaric Oxygen Therapy: Results through June 2021. Undersea Hyperb Med. 2022;49(3):275\u201387.","DOI":"10.22462\/05.06.2022.1"},{"key":"1350_CR79","doi-asserted-by":"crossref","unstructured":"Feldmeier JJ, Kirby JP, Gelly HB, Robins M, Peters J, Gruhn P, et al. Controlled cms data demonstrates a cost and clinical advantage for hyperbaric oxygen for radiation cystitis. Undersea Hyperb Med. 2024;51(2):145\u201357.","DOI":"10.22462\/704"},{"key":"1350_CR80","doi-asserted-by":"publisher","unstructured":"Platzer V, Perez G, Galinier A, Genestal M, Riu-Poulenc B, Gonzalez L, et al. Protein and micronutrient deficiencies in patients with radiation cystitis and outcome after hyperbaric oxygen therapy. Clin Nutr ESPEN. 2018;23:141\u20137. https:\/\/doi.org\/10.1016\/j.clnesp.2017.10.012.","DOI":"10.1016\/j.clnesp.2017.10.012."}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11934-026-01350-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-026-01350-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:31:51Z","timestamp":1787020311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11934-026-01350-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1350"],"URL":"https:\/\/doi.org\/10.1007\/s11934-026-01350-3","relation":{},"ISSN":["1534-6285"],"issn-type":[{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"I certify that this research complied with ethical standards, following the Helsinki Declaration (1975, revised in 2013) and relevant national regulations.","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"40"}}